Jie Mu

2.4k citations
23 papers · 1.5k indexed · h-index 15
Topics
Immune Cell Function and Interaction (7 papers)Immunotherapy and Immune Responses (5 papers)T-cell and B-cell Immunology (5 papers)
Partner nations
United StatesJapanChina

In The Last Decade

Jie Mu

23 papers receiving 1.4k citations

Peers

Jie Mu
Comparison fields: 5 of 85
  • Immunology 971
  • Molecular Biology 495
  • Oncology 414
  • Genetics 99
  • Hematology 94
Replace Vrajesh V. Parekh with:
Vrajesh V. Parekh United States
Hakuo Ikegami Japan
Subhashini Srinivasan United States
Gholamreza Hassanzadeh Ghassabeh Belgium
D E Kern United States
H Yagita Japan
Theresa Truitt United States
Guy D. Bonnard United States
Lianxian Cui China
Christian Davrinche France
Jie Mu relative to Vrajesh V. Parekh United States Vrajesh V. Parekh's profile →
Citations per field
00.5×1.5×
Vrajesh V. Parekh · 1×
Citations per year

Countries citing papers authored by Jie Mu

Since Specialization
Citations

This map shows the geographic impact of Jie Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Mu more than expected).

Fields of papers citing papers by Jie Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Mu. The network helps show where Jie Mu may publish in the future.

Co-authorship network of co-authors of Jie Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Mu. A scholar is included among the top collaborators of Jie Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Mu. Jie Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 23
3 108
4 33
5 29
6 4
7 2
8 13
9 9
10 174
11 13
12 52
13 93
14 11
15 18
16 280
17 55
18 40
19 78
20
Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.
120

About Jie Mu

Jie Mu is a scholar working on Immunology, Cancer Research and Oncology, having authored 23 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Immunology (971 citations), Oncology (414 citations) and Hematology (94 citations). Jie Mu has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Hiromi Fujiwara, Haruki Okamura, Seiji Maruo, Steven C. Clark, Michio Tomura, Hyun‐Jong Ahn, T Hamaoka, Xuguang Tai, Dinah S. Singer and H Fujiwara. Their work appears in journals such as Proceedings of the National Academy of Sciences, Immunity and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026